Latest Biocon Ltd. News & Updates

Washington, March 4 (IANS) The U.S. International Trade Commission (USITC) has received a complaint alleging that biosimilar versions of the cancer drug pertuzumab imported into the United States violate U.S. trade law. ​ Several entities of India’s largest biopharmaceutical company, Biocon, have been named as respondents.​The notice was published in the Federal Register. It said the complaint was filed by the world’s top biotech company, Genentech, on February 27, 2026.​“The Commiss…